Global Ankylosing Spondylitis (AS) Market growing by Increasing Market Share andPosted by ganesha on November 11th, 2019 Global Ankylosing Spondylitis (AS) Market By Drug Type (Nonsteroidal Anti-Inflammatory Drugs, TNF Blockers, Immunosuppressive Drugs, Anti-Inflammatory Drugs, Steroids, JAK Inhibitors, Others), Application (Juveniles, Adults), Molecule (Biologics, Biosimilars, Small Molecules), Route of Administration (Parenteral, Oral) Market Analysis: Global Ankylosing Spondylitis (AS) MarketGlobal ankylosing spondylitis (AS) market is set to witness a substantial CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of ankylosing spondylitis worldwide and increasing healthcare expenditure is the factor for the growth of this market. Get Exclusive Sample Report: @ Market Definition: Global Ankylosing Spondylitis (AS) MarketAnkylosing spondylitis or AS is a kind of an arthritis which usually affect the spine of the patient by reducing the flexibility. This usually causes discomfort, pain, stiffness and inflammation. In some cases, spines get fused in fixed position due to new bone formation. Usually drugs such as nonsteroidal anti- inflammatory, TNF blockers, steroids, JAK inhibitors and others are used to treat this disease. This disease mainly creates stiffness in areas such as small joints, ribs, heels, hips and others. According to National Health and Nutritional Examination Survey (NHANES), in the U.S., 0.5 percent of the population or about 1.6 million people are affected by ankylosing spondylitis. Market Drivers
Market Restraints
Segmentation: Global Ankylosing Spondylitis (AS) MarketBy Drug Type o Nonsteroidal Anti-Inflammatory Drugs o TNF Blockers o Immunosuppressive Drugs o Anti-Inflammatory Drugs o Steroids o JAK Inhibitors o Others By Application o Juveniles o Adults By Molecule o Biologics o Biosimilars o Small Molecules By Route of Administration o Parenteral o Oral Key Developments in the Market:
Competitive Analysis: Global ankylosing spondylitis (AS) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of ankylosing spondylitis (AS) market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Contact: Data Bridge Market Research Tel: +1-888-387-2818
Report Related Like it? Share it!More by this author |